Minimizing aggregates when nebulizing antibody Fab fragments: high thermostability and high concentration are key

Josi Ann Steinke, Pierre-Louis Destruel, Benjamin Weiche, Stefan Dengl, Gregoire Schwach, Gerhard Pohlmann, Marlon J. Hinner

Open source

DOI
10.1016/j.ejps.2026.107446
Published
2026-06
Container
European Journal of Pharmaceutical Sciences
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejps.2026.107446,
  title = {Minimizing aggregates when nebulizing antibody Fab fragments: high thermostability and high concentration are key},
  author = {Josi Ann Steinke and Pierre-Louis Destruel and Benjamin Weiche and Stefan Dengl and Gregoire Schwach and Gerhard Pohlmann and Marlon J. Hinner},
  year = {2026},
  journal = {European Journal of Pharmaceutical Sciences},
  doi = {10.1016/j.ejps.2026.107446},
  url = {https://doi.org/10.1016/j.ejps.2026.107446}
}

RIS

TY  - JOUR
TI  - Minimizing aggregates when nebulizing antibody Fab fragments: high thermostability and high concentration are key
AU  - Josi Ann Steinke
AU  - Pierre-Louis Destruel
AU  - Benjamin Weiche
AU  - Stefan Dengl
AU  - Gregoire Schwach
AU  - Gerhard Pohlmann
AU  - Marlon J. Hinner
PY  - 2026
JO  - European Journal of Pharmaceutical Sciences
DO  - 10.1016/j.ejps.2026.107446
UR  - https://doi.org/10.1016/j.ejps.2026.107446
ER  - 

APA

Steinke, J. A., Destruel, P., Weiche, B., Dengl, S., Schwach, G., Pohlmann, G., & Hinner, M. J. (2026). Minimizing aggregates when nebulizing antibody Fab fragments: high thermostability and high concentration are key. European Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.ejps.2026.107446

Source records